Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology — Minneapolis, Minnesota

Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology is a clinical research site located in Minneapolis, Minnesota, United States 55404.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology has participated in 2 clinical trials.

Therapeutic areas: Tumor Pathway Activations Inhibited by Dovitinib, PI3K Pathway Activated Tumors.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology?

Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology conducted?

Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology has 2 clinical trials on record. Their work covers Tumor Pathway Activations Inhibited by Dovitinib, PI3K Pathway Activated Tumors.

Is Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology accredited by Crixeo Health?

Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.